Skip to main content

Professor
Department of Medicine
Director, Immunocompromised Host Infectious Diseases Section

Publications

  1. Wang M, Ge L, Chen L, Komarow L, Hanson B, Reyes J, Cober E, Alenazi T, Zong Z, Xie Q, Liu Z, Li L, Yu Y, Gao H, Kanj SS, Figueroa J, Herc E, Cordova E, Weston G, Ananth Tambyah P, Garcia-Diaz J, Kaye KS, Dhar S, Munita JM, Salata RA, Vilchez S, Stryjewski ME, Villegas Botero MV, Iovleva A, Evans S, Baum K, Hill C, Kreiswirth BN, Patel R, Paterson DL, Arias CA, Bonomo RA, Chambers HF, Fowler VG, Satlin MJ, van Duin D, Doi Y. Clinical Outcomes and Bacterial Characteristics of Carbapenem-Resistant Acinetobacter baumannii Among Patients from Different Global Regions. Clin Infect Dis. 2023 Sep 20;. doi: 10.1093/cid/ciad556. [Epub ahead of print] PubMed PMID: 37738153.
  2. Mackow NA, Yahav D, Williams FN, van Duin D. Which trial do we need? Evaluation of systemic antibiotics as primary prophylaxis in mechanically ventilated patients with burn injuries. Clin Microbiol Infect. 2023 Sep;29(9):1107-1109. doi: 10.1016/j.cmi.2023.04.007. Epub 2023 Apr 12. PubMed PMID: 37059223.
  3. Boutzoukas AE, Komarow L, Chen L, Hanson B, Kanj SS, Liu Z, Salcedo Mendoza S, Ordoñez K, Wang M, Paterson DL, Evans S, Ge L, Giri A, Hill C, Baum K, Bonomo RA, Kreiswirth B, Patel R, Arias CA, Chambers HF, Fowler VG, van Duin D. International Epidemiology of Carbapenemase-Producing Escherichia coli. Clin Infect Dis. 2023 Aug 22;77(4):499-509. doi: 10.1093/cid/ciad288. PubMed PMID: 37154071; PubMed Central PMCID: PMC10444003.
  4. Tamma PD, Aitken SL, Bonomo RA, Mathers AJ, van Duin D, Clancy CJ. Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections. Clin Infect Dis. 2023 Jul 18;. doi: 10.1093/cid/ciad428. [Epub ahead of print] PubMed PMID: 37463564.
  5. Gilboa M, van Duin D, Yahav D. Which trial do we need? How to treat Pseudomonas aeruginosa bacteraemia-proposal for an umbrella randomized controlled trial. Clin Microbiol Infect. 2023 Jul;29(7):829-831. doi: 10.1016/j.cmi.2023.03.029. Epub 2023 Mar 31. PubMed PMID: 37004748.
  6. Brown DR, Henderson HI, Ruegsegger L, Moody J, van Duin D. Socioeconomic disparities in the prevalence of multidrug resistance in Enterobacterales. Infect Control Hosp Epidemiol. 2023 Jun 30;:1-3. doi: 10.1017/ice.2023.116. [Epub ahead of print] PubMed PMID: 37385945.
  7. Marley G, Tan RKJ, Wu D, Wang T, Sun M, Sheng Q, Holly ME, Hlatshwako TG, Wang C, Tang W, Ramaswamy R, Yang L, Luo D, Sylvia SS, Gray K, Van Duin D, Zheng H, Tucker JD. Pay-it-forward gonorrhea and chlamydia testing among men who have sex with men and male STD patients in China: the PIONEER pragmatic, cluster randomized controlled trial protocol. BMC Public Health. 2023 Jun 20;23(1):1182. doi: 10.1186/s12889-023-16095-8. PubMed PMID: 37337181; PubMed Central PMCID: PMC10280958.
  8. Tran M, Palmer S, Moore DT, Bartelt L, Friedland A, Grgic T, Lachiewicz A, Ptachcinski J, Sena A, Trepte M, van Duin D, Andermann TM, Shaw R. Utility of Urine Cultures During Febrile Neutropenia Workup in Hematopoietic Stem Cell Transplantation Recipients Without Urinary Symptoms. Open Forum Infect Dis. 2023 May;10(5):ofad236. doi: 10.1093/ofid/ofad236. eCollection 2023 May. PubMed PMID: 37265665; PubMed Central PMCID: PMC10230562.
  9. Holowka T, van Duin D, Bartelt LA. Impact of childhood malnutrition and intestinal microbiota on MDR infections. JAC Antimicrob Resist. 2023 Apr;5(2):dlad051. doi: 10.1093/jacamr/dlad051. eCollection 2023 Apr. Review. PubMed PMID: 37102119; PubMed Central PMCID: PMC10125725.
  10. Reyes J, Komarow L, Chen L, Ge L, Hanson BM, Cober E, Herc E, Alenazi T, Kaye KS, Garcia-Diaz J, Li L, Kanj SS, Liu Z, Oñate JM, Salata RA, Marimuthu K, Gao H, Zong Z, Valderrama-Beltrán SL, Yu Y, Tambyah P, Weston G, Salcedo S, Abbo LM, Xie Q, Ordoñez K, Wang M, Stryjewski ME, Munita JM, Paterson DL, Evans S, Hill C, Baum K, Bonomo RA, Kreiswirth BN, Villegas MV, Patel R, Arias CA, Chambers HF, Fowler VG Jr, Doi Y, van Duin D, Satlin MJ. Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study. Lancet Microbe. 2023 Mar;4(3):e159-e170. doi: 10.1016/S2666-5247(22)00329-9. Epub 2023 Feb 9. PubMed PMID: 36774938; PubMed Central PMCID: PMC10016089.

Complete list of publications

 

David van Duin, MD, PhD, FIDSA, FAST